The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Ocular Preparations: The Formulation Approach
Abstract
The main aim of pharmacotherapeutics is the attainment of an effective drug concentration at the intended site of action for a sufficient period of time to elicit the response. A major problem being faced in ocular therapeutics is the attainment of an optimal concentration at the site of action. Poor bioavailability of drugs from ocular dosage forms is mainly due to the tear production, non-productive absorption, transient residence time, and impermeability of corneal epithelium. This article reviews: (1) the barriers that decrease the bioavailability of an ophthalmic drug; (2) the objectives to be considered in producing optimal formulations; and (3) the approaches being used to improve the corneal penetration of a drug molecule and delay its elimination from the eye. The focus of this review is on the recent developments in topical ocular drug delivery systems, the rationale for their use, their drug release mechanism, and the characteristic advantages and limitations of each system. In addition, the review attempts to give various analytical procedures including the animal models and other models required for bioavailability and pharmacokinetic studies. The latter can aid in the design and predictive evaluation of newer delivery systems. The dosage forms are divided into the ones which affect the precorneal parameters, and those that provide a controlled and continuous delivery to the pre- and intraocular tissues. The systems discussed include: (a) the commonly used dosage forms such as gels, viscosity imparting agents, ointments, and aqueous suspensions; (b) the newer concept of penetration enhancers, phase transition systems, use of cyclodextrins to increase solubility of various drugs, vesicular systems, and chemical delivery systems such as the prodrugs; (c) the developed and under-development controlled/continuous drug delivery systems including ocular inserts, collagen shields, ocular films, disposable contact lenses, and other new ophthalmic drug delivery systems; and (d) the newer trends directed towards a combination of drug delivery technologies for improving the therapeutic response of a non-efficacious drug. The fruitful resolution of the above-mentioned technological suggestions can result in a superior dosage form for both topical and intraocular ophthalmic application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
In vitro evaluation of the mucoadhesive properties of chitosan microspheres
He, P., Davis, S. S., & Illum, L. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00027-1 · Cited by 667
Frömming, K.-H., & Szejtli, J. (1994) · Topics in Inclusion Science · doi:10.1007/978-94-015-8277-3 · Cited by 658
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 627
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
LEE, V. H. L., & ROBINSON, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 503
An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery
Smart, J. D., Kellaway, I. W., & Worthington, H. E. C. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb04377.x · Cited by 467
Ch'Ng, H. S., Park, H., Kelly, P., & Robinson, J. R. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740407 · Cited by 443
Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion
Park, K., & Robinson, J. R. (1984) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(84)90154-6 · Cited by 420
Cited by
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Marsac, P. J., Li, T., & Taylor, L. S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9721-1 · Cited by 507
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Bachu, R., Chowdhury, P., Al-Saedi, Z., Karla, P., & Boddu, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010028 · Cited by 421
Applications of nanoparticles in ophthalmology
Diebold, Y., & Calonge, M. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.002 · Cited by 392
Recent trends on gellan gum blends with natural and synthetic polymers: A review
Zia, K. M., Tabasum, S., Khan, M. F., Akram, N., Akhter, N., Noreen, A., & Zuber, M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.099 · Cited by 370
Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
Hathout, R. M., Mansour, S., Mortada, N. D., & Guinedi, A. S. (2007) · AAPS PharmSciTech · doi:10.1208/pt0801001 · Cited by 346
Recent advances in ocular drug delivery
Achouri, D., Alhanout, K., Piccerelle, P., & Andrieu, V. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.736515 · Cited by 335
Drug delivery to the posterior segment of the eye
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.12.004 · Cited by 335
Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
Abdelbary, G., & El-gendy, N. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9105-1 · Cited by 333
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery
Jiao, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.002 · Cited by 314
Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb
Lallemand, F., Daull, P., Benita, S., Buggage, R., & Garrigue, J.-S. (2012) · Journal of Drug Delivery · doi:10.1155/2012/604204 · Cited by 314
Orotransmucosal drug delivery systems: A review
Madhav, N. V. S., Shakya, A. K., Shakya, P., & Singh, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.07.016 · Cited by 282
Imprinted soft contact lenses as norfloxacin delivery systems
Alvarez-Lorenzo, C., Yañez, F., Barreiro-Iglesias, R., & Concheiro, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.003 · Cited by 252
Metadata
- Authors
- Pal Kaur, I., & Kanwar, M.
- Venue
- Drug Development and Industrial Pharmacy
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 28
- Issue
- 5
- Pages
- 473-493
- ISSN
- 0363-9045 (ISSN-L)
- 1520-5762
- OpenAlex
- W2115305419
- Cited by
- 310
- References
- 73
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.